SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-054017
Filing Date
2020-11-16
Accepted
2020-11-16 07:41:04
Documents
68
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q freq-10q_20200930.htm 10-Q 3303507
2 EX-3.2.1 freq-ex321_142.htm EX-3.2.1 502698
3 EX-31.1 freq-ex311_7.htm EX-31.1 18094
4 EX-31.2 freq-ex312_9.htm EX-31.2 18133
5 EX-32.1 freq-ex321_6.htm EX-32.1 9665
6 EX-32.2 freq-ex322_8.htm EX-32.2 9696
  Complete submission text file 0001564590-20-054017.txt   9369093

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT freq-20200930.xml EX-101.INS 1550144
8 XBRL TAXONOMY EXTENSION SCHEMA freq-20200930.xsd EX-101.SCH 55112
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE freq-20200930_cal.xml EX-101.CAL 50334
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE freq-20200930_def.xml EX-101.DEF 216788
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20200930_lab.xml EX-101.LAB 475250
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20200930_pre.xml EX-101.PRE 361439
Mailing Address 19 PRESIDENTIAL WAY, SUITE 203 WOBURN MA 01801
Business Address 19 PRESIDENTIAL WAY, SUITE 203 WOBURN MA 01801 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39062 | Film No.: 201313693
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences